Название продукции:Triphenylmethyl chloride

IUPAC Name:

CAS:76-83-5
Молекулярная формула:C19H15Cl
Чистота:95%+
Номер в каталоге:CM000181
Молекулярная масса:278.78

Упаковочная единица Доступно для заказа Цена ($) Количество
CM000181-500g 1-2 Weeks Ůǟ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:76-83-5
Молекулярная формула:C19H15Cl
Точка плавления:-
Smiles-код:ClC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3
Плотность:
Номер в каталоге:CM000181
Молекулярная масса:278.78
Точка кипения:
Номер Mdl:MFCD00000813
Хранение:

Column Infos

Zegocractin
CalciMedica announces positive topline data from phase 2b CARPO trial of Auxora™ in Acute Pancreatitis (AP). The trial met primary objective with statistically significant dose response. Calcium release–activated calcium (CRAC) channels are involved in activating T cells, and responsible for regulating calcium-dependent inflammatory pathways or tissue cell injury pathways. AP is a potentially life-threatening inflammatory disease of the pancreas featured by aberrant signaling of calcium.
CalciMedica’s Auxora is a potent and selective intravenous formulated CRAC channel inhibitor containing the active ingredient Zegocractin. It is being developed for the treatment of acute inflammatory and immunologic illnesses, including severe AP, AIPT, AKI, and severe acute respiratory diseases including AHRF, and ARDS.